• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies.使用多种宫颈标本采集策略对基于聚合酶链反应(PCR)和杂交捕获的人乳头瘤病毒检测系统进行比较。
J Clin Microbiol. 1998 Nov;36(11):3248-54. doi: 10.1128/JCM.36.11.3248-3254.1998.
2
Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens.杂交捕获管试验与聚合酶链反应检测宫颈标本中人乳头瘤病毒DNA的比较
J Clin Microbiol. 1997 Sep;35(9):2262-5. doi: 10.1128/jcm.35.9.2262-2265.1997.
3
Stability of PreservCyt for Hybrid Capture (HC II) HPV test.用于杂交捕获(HC II)人乳头瘤病毒检测的PreservCyt保存稳定性
Diagn Cytopathol. 2005 May;32(5):260-3. doi: 10.1002/dc.20232.
4
Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction.通过第二代杂交捕获法和聚合酶链反应确定的、因常规宫颈癌筛查或阴道镜检查而招募的女性中的生殖器人乳头瘤病毒感染情况。
Diagn Mol Pathol. 1999 Sep;8(3):157-64. doi: 10.1097/00019606-199909000-00009.
5
Detection of human papillomavirus DNA in cervical lavage specimens by a nonisotopic consensus PCR assay.采用非同位素一致性聚合酶链反应检测宫颈灌洗标本中的人乳头瘤病毒DNA。
J Clin Microbiol. 1995 Aug;33(8):1973-8. doi: 10.1128/jcm.33.8.1973-1978.1995.
6
Validation of ThermoFisher's Papspin for human papillomavirus detection in cervicovaginal specimens using PCR with GP5+/GP6+ primers and the Hybrid Capture II assay.验证 ThermoFisher 的 Papspin 用于人乳头瘤病毒检测,使用 PCR 与 GP5+/GP6+引物和杂交捕获 II 检测试剂盒检测宫颈阴道标本。
Clin Microbiol Infect. 2010 Jun;16(6):671-5. doi: 10.1111/j.1469-0691.2009.02943.x. Epub 2009 Aug 18.
7
Detection of human papillomavirus in cervical cell specimens by hybrid capture and PCR with different primers.采用杂交捕获法和不同引物的聚合酶链反应检测宫颈细胞标本中的人乳头瘤病毒。
Acta Biochim Pol. 2006;53(3):603-7. Epub 2006 Oct 1.
8
Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL.在巴氏涂片报告为非典型鳞状细胞意义不明确(ASCUS)和低度鳞状上皮内病变(LSIL)的女性中,两种检测致癌性人乳头瘤病毒(HPV)方法的比较。
J Fam Pract. 1998 Feb;46(2):136-41.
9
Human papillomavirus detection by the hybrid capture II assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions.采用杂交捕获II试验检测人乳头瘤病毒:一种用于筛选宫颈涂片正常但有发生宫颈病变风险女性的可靠检测方法。
Diagn Mol Pathol. 2000 Sep;9(3):145-50. doi: 10.1097/00019606-200009000-00004.
10
Universal Collection Medium (UCM) is as suitable as the Standard Transport Medium (STM) for Hybrid Capture II (HC-2) assay.
J Clin Virol. 2006 May;36(1):32-5. doi: 10.1016/j.jcv.2005.12.011. Epub 2006 Feb 17.

引用本文的文献

1
A Multianalyte Electrochemical Genosensor for the Detection of High-Risk HPV Genotypes in Oral and Cervical Cancers.一种用于检测口腔和宫颈癌中高危 HPV 基因型的多分析物电化学基因传感器。
Biosensors (Basel). 2022 May 2;12(5):290. doi: 10.3390/bios12050290.
2
Hidden mover-stayer model for disease progression accounting for misclassified and partially observed diagnostic tests: Application to the natural history of human papillomavirus and cervical precancer.用于疾病进展的隐藏移动-停留模型,考虑到分类错误和部分观察到的诊断测试:在人乳头瘤病毒和宫颈癌前病变自然史中的应用。
Stat Med. 2021 Jul 10;40(15):3460-3476. doi: 10.1002/sim.8977. Epub 2021 Apr 12.
3
The potential of RNA as a target for national screening of pre-cancer.RNA作为全国性癌症前期筛查靶点的潜力。
J Public Health Afr. 2018 Dec 21;9(3):866. doi: 10.4081/jphia.2018.866.
4
Self-collected Pap smears may provide an acceptable and effective method of cervical cancer screening.自行采集的巴氏涂片可能是一种可接受且有效的宫颈癌筛查方法。
Health Sci Rep. 2018 Apr 6;1(5):e33. doi: 10.1002/hsr2.33. eCollection 2018 May.
5
Colorimetric human papillomavirus DNA assay based on the retardation of avidin-induced aggregation of gold nanoparticles.基于金纳米颗粒的亲和素诱导聚集的延迟作用的比色人乳头瘤病毒 DNA 检测法。
Mikrochim Acta. 2018 Nov 9;185(12):537. doi: 10.1007/s00604-018-3065-2.
6
Comparison of the PANArray HPV Genotyping Chip Test with the Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of HPV in ASCUS Women.用于检测非典型鳞状细胞意义不明确(ASCUS)女性人乳头瘤病毒(HPV)的PANArray HPV基因分型芯片检测与Cobas 4800 HPV检测及杂交捕获2检测的比较
Yonsei Med J. 2018 Jul;59(5):662-668. doi: 10.3349/ymj.2018.59.5.662.
7
Hybrid capture as a tool for cervical lesions screening in HIV-infected women: insights from a Brazilian cohort.杂交捕获法作为HIV感染女性宫颈病变筛查工具:来自巴西队列的见解。
Braz J Infect Dis. 2018 Jan-Feb;22(1):16-23. doi: 10.1016/j.bjid.2017.10.007. Epub 2017 Dec 6.
8
The PapilloCheck Assay for Detection of High-Grade Cervical Intraepithelial Neoplasia.用于检测高级别宫颈上皮内瘤变的PapilloCheck检测法
J Clin Microbiol. 2015 Nov;53(11):3553-9. doi: 10.1128/JCM.01578-15. Epub 2015 Sep 2.
9
A PCR-based microwell-plate hybrid capture assay for high-risk human papillomavirus.一种用于高危型人乳头瘤病毒的基于聚合酶链反应的微孔板杂交捕获检测法。
Arch Virol. 2014 Dec;159(12):3365-70. doi: 10.1007/s00705-014-2186-0. Epub 2014 Aug 5.
10
Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) study.杂交捕获 2 检测分析特异性的临床影响:来自宫颈癌新技术(NTCC)研究的数据。
J Clin Microbiol. 2013 Sep;51(9):2901-7. doi: 10.1128/JCM.01047-13. Epub 2013 Jun 26.

本文引用的文献

1
Viral testing for genital human papillomavirus infections: recent progress and clinical potentials.生殖器人乳头瘤病毒感染的病毒检测:最新进展与临床潜力
Int J Gynecol Cancer. 1995 Sep;5(5):321-328. doi: 10.1046/j.1525-1438.1995.05050321.x.
2
Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.采用单杂交、反向线印迹检测方法,利用L1共识PCR产物对27种人乳头瘤病毒进行基因分型。
J Clin Microbiol. 1998 Oct;36(10):3020-7. doi: 10.1128/JCM.36.10.3020-3027.1998.
3
Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens.杂交捕获管试验与聚合酶链反应检测宫颈标本中人乳头瘤病毒DNA的比较
J Clin Microbiol. 1997 Sep;35(9):2262-5. doi: 10.1128/jcm.35.9.2262-2265.1997.
4
Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening.传统巴氏涂片与液基薄层系统用于宫颈癌筛查的比较。
Obstet Gynecol. 1997 Aug;90(2):278-84. doi: 10.1016/S0029-7844(97)00228-7.
5
Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project.哥斯达黎加一个农村省份宫颈癌前病变基于人群的自然史研究的设计与方法:瓜纳卡斯特项目
Rev Panam Salud Publica. 1997 May;1(5):362-75. doi: 10.1590/s1020-49891997000500005.
6
Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.收集于液体缓冲液中的宫颈标本适用于细胞学筛查和辅助人乳头瘤病毒检测。
Cancer. 1997 Apr 25;81(2):89-97.
7
Screening for cervical intraepithelial neoplasia grade 2/3: validity of cytologic study, cervicography, and human papillomavirus detection.宫颈上皮内瘤变2/3级的筛查:细胞学检查、宫颈造影及人乳头瘤病毒检测的有效性
Am J Obstet Gynecol. 1996 May;174(5):1534-41. doi: 10.1016/s0002-9378(96)70602-6.
8
Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening.
J Obstet Gynaecol Res. 1996 Dec;22(6):629-36. doi: 10.1111/j.1447-0756.1996.tb01081.x.
9
Comparison of PCR and hybrid capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection.聚合酶链反应(PCR)与杂交捕获法在检测感染人类免疫缺陷病毒高风险的注射吸毒女性中人类乳头瘤病毒的比较
J Clin Microbiol. 1997 Feb;35(2):517-9. doi: 10.1128/jcm.35.2.517-519.1997.
10
Analytic sensitivities of hybrid-capture, consensus and type-specific polymerase chain reactions for the detection of human papillomavirus type 16 DNA.杂交捕获法、共识法和型特异性聚合酶链反应检测人乳头瘤病毒16型DNA的分析敏感性
J Med Virol. 1996 Aug;49(4):319-24. doi: 10.1002/(SICI)1096-9071(199608)49:4<319::AID-JMV10>3.0.CO;2-5.

使用多种宫颈标本采集策略对基于聚合酶链反应(PCR)和杂交捕获的人乳头瘤病毒检测系统进行比较。

Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies.

作者信息

Peyton C L, Schiffman M, Lörincz A T, Hunt W C, Mielzynska I, Bratti C, Eaton S, Hildesheim A, Morera L A, Rodriguez A C, Herrero R, Sherman M E, Wheeler C M

机构信息

Department of Molecular Genetics and Microbiology, University of New Mexico, Albuquerque, New Mexico, USA.

出版信息

J Clin Microbiol. 1998 Nov;36(11):3248-54. doi: 10.1128/JCM.36.11.3248-3254.1998.

DOI:10.1128/JCM.36.11.3248-3254.1998
PMID:9774574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC105310/
Abstract

This study compared the performances of three human papillomavirus (HPV) detection tests with specimens collected by three alternative procedures. The HPV tests included the Hybrid Capture Tube test (HCT), the microplate-based Hybrid Capture II test (HC II), and the MY09-MY11 L1 consensus primer PCR-based assay. Initial cervical specimens were collected from study subjects with a broom device, and after Papanicolaou smears were made, residual specimens were placed into PreservCyt (PC), a liquid cytology medium. A second specimen was collected from each subject and placed into Digene Specimen Transport Medium (STM). The device for collection of the second specimen alternated with consecutive subjects between a conical cytology brush and a Dacron swab. At the 1.0-pg/ml cutoff, the results of the HC II agreed well with those of the PCR. Specifically, when PCR data were restricted to the types found by the HC II (HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68), there was greater than 90% agreement between the HC II and PCR results with both STM and PC. At a lower cutoff (0.2 pg/ml), HC II-positive results increased further, especially when the test was applied to the PC specimens. However, false-positive HC II results were more often observed at the 0.2-pg/ml cutoff. HC II yielded the highest HPV positivity with specimens placed into PC, followed by specimens collected with a conical brush and placed into STM and, last, by those collected with a Dacron swab and placed into STM. Our results demonstrate the utility of both the STM and PC specimen collection methods and show good agreement between the HC II and PCR.

摘要

本研究比较了三种人乳头瘤病毒(HPV)检测试验对通过三种不同程序采集的标本的检测性能。HPV检测试验包括杂交捕获管试验(HCT)、基于微孔板的杂交捕获II试验(HC II)以及基于MY09-MY11 L1共有引物PCR的检测方法。最初的宫颈标本是用扫帚状装置从研究对象中采集的,在制作巴氏涂片后,将剩余标本放入PreservCyt(PC),一种液体细胞学培养基中。从每个研究对象采集第二份标本并放入Digene标本转运培养基(STM)中。采集第二份标本的装置在连续的研究对象之间交替使用,分别为锥形细胞学刷和涤纶拭子。在1.0 pg/ml的临界值下,HC II的检测结果与PCR的结果高度一致。具体而言,当将PCR数据限制在HC II检测出的类型(HPV 16、18、31、33、35、39、45、51、52、56、58、59和68型)时,对于STM和PC标本,HC II与PCR结果的一致性均超过90%。在较低临界值(0. .2 pg/ml)时,HC II阳性结果进一步增加,尤其是当该检测应用于PC标本时。然而,在0.2 pg/ml临界值时,更常观察到HC II的假阳性结果。对于放入PC中的标本,HC II检测出的HPV阳性率最高,其次是用锥形刷采集并放入STM中的标本,最后是用涤纶拭子采集并放入STM中的标本。我们的结果证明了STM和PC标本采集方法的实用性,并显示出HC II与PCR之间具有良好的一致性。